|
US3169967A
(en)
|
1957-11-14 |
1965-02-16 |
Ciba Geigy Corp |
Methyl o-lower alkanoyl-reserpates
|
|
US3037980A
(en)
|
1955-08-18 |
1962-06-05 |
Burroughs Wellcome Co |
Pyrrolopyrimidine vasodilators and method of making them
|
|
DE1770420U
(de)
|
1958-02-27 |
1958-07-17 |
Tara Union G M B H |
Blumentopf aus kunststoff.
|
|
US3506643A
(en)
|
1966-12-09 |
1970-04-14 |
Max Thiel |
N**6-aralkyl-adenosine derivatives
|
|
DE2139107A1
(de)
|
1971-08-04 |
1973-02-15 |
Merck Patent Gmbh |
Heterocyclisch substituierte adenosinverbindungen
|
|
US3814251A
(en)
|
1972-08-09 |
1974-06-04 |
Sperry Rand Corp |
Power transmission
|
|
US3962443A
(en)
|
1972-08-14 |
1976-06-08 |
Dainippon Pharmaceutical Co., Ltd. |
Antibacterial pharmaceutical compositions and processes for preparation thereof
|
|
DE2248232A1
(de)
|
1972-10-02 |
1974-04-11 |
Basf Ag |
4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
|
AR204003A1
(es)
|
1973-04-03 |
1975-11-12 |
Dainippon Pharmaceutical Co |
Procedimiento para preparar compuestos derivados del acido 2-(1-piperazinil)-5-oxopirido-(2,3-d)pirimidino-6-carboxilico y sus sales farmaceuticamente aceptables
|
|
US3936454A
(en)
|
1973-08-14 |
1976-02-03 |
Warner-Lambert Company |
5-Amino-4-chloro-6-(substituted amino)-pyrimidines
|
|
US3862189A
(en)
|
1973-08-14 |
1975-01-21 |
Warner Lambert Co |
Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
|
|
DK3375A
(enExample)
|
1974-01-25 |
1975-09-15 |
Ciba Geigy Ag |
|
|
JPS587626B2
(ja)
|
1974-02-13 |
1983-02-10 |
大日本製薬株式会社 |
ナフチリジン オヨビ キノリンユウドウタイノセイホウ
|
|
JPS50111080U
(enExample)
|
1974-02-21 |
1975-09-10 |
|
|
|
JPS5625234Y2
(enExample)
|
1976-01-17 |
1981-06-15 |
|
|
|
JPS5359663A
(en)
|
1976-11-09 |
1978-05-29 |
Sumitomo Chem Co Ltd |
2-halogeno methyl indole derivatives and process for praparation of the same
|
|
JPS52106897A
(en)
|
1977-01-10 |
1977-09-07 |
Dainippon Pharmaceut Co Ltd |
Synthesis of piperazine derivatives
|
|
JPS5392767A
(en)
|
1977-01-27 |
1978-08-15 |
Sumitomo Chem Co Ltd |
Preparation of 2-phthalimidomethylindole derivatives
|
|
JPS5625234A
(en)
|
1979-08-02 |
1981-03-11 |
Hitachi Denshi Ltd |
Dropout display system
|
|
JPS56123981U
(enExample)
|
1980-02-20 |
1981-09-21 |
|
|
|
JPS56123981A
(en)
|
1981-02-23 |
1981-09-29 |
Dainippon Pharmaceut Co Ltd |
Preparation of 1,4-disubstituted piperazine
|
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
|
JPS5883698U
(ja)
|
1981-11-27 |
1983-06-06 |
石川島播磨重工業株式会社 |
熱交換器
|
|
JPS58162949A
(ja)
|
1982-03-20 |
1983-09-27 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6067709U
(ja)
|
1983-10-14 |
1985-05-14 |
三洋電機株式会社 |
ヘア−ドライヤ−
|
|
JPS60140373U
(ja)
|
1984-02-28 |
1985-09-17 |
東洋ハ−ネス株式会社 |
ワイヤハ−ネスのア−ス構造
|
|
JPS6190153A
(ja)
|
1984-10-09 |
1986-05-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPS6263591U
(enExample)
|
1985-06-29 |
1987-04-20 |
|
|
|
JPS62103640A
(ja)
|
1985-07-18 |
1987-05-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS635783Y2
(enExample)
|
1985-10-17 |
1988-02-17 |
|
|
|
JPS62103640U
(enExample)
|
1985-12-18 |
1987-07-02 |
|
|
|
JPH07119970B2
(ja)
|
1986-04-18 |
1995-12-20 |
富士写真フイルム株式会社 |
画像形成方法
|
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
|
CA1324609C
(en)
|
1986-07-30 |
1993-11-23 |
Eastman Kodak Company |
Photographic element and process
|
|
JPS6427257U
(enExample)
|
1987-08-11 |
1989-02-16 |
|
|
|
US4861701A
(en)
|
1987-10-05 |
1989-08-29 |
Eastman Kodak Company |
Photographic element and process comprising a compound which comprises two timing groups in sequence
|
|
AT388372B
(de)
|
1987-10-08 |
1989-06-12 |
Tanabe Seiyaku Co |
Neue naphthalinderivate und sie enthaltende pharmazeutika
|
|
JPH01250316A
(ja)
|
1987-12-28 |
1989-10-05 |
Tanabe Seiyaku Co Ltd |
抗脂血剤
|
|
EP0364598A4
(en)
|
1988-03-02 |
1992-01-15 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3,4-dihydrothieno 2,3-d¨pyrimidine compounds and pharmaceutical application thereof
|
|
US5208250A
(en)
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
|
JPH054831Y2
(enExample)
|
1988-11-22 |
1993-02-08 |
|
|
|
UA27031A1
(uk)
|
1990-04-25 |
2000-02-28 |
Ніссан Кемікал Індастріз Лтд |
Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові
|
|
SU1712359A1
(ru)
|
1990-05-07 |
1992-02-15 |
Уфимский Нефтяной Институт |
Гидрохлорид 8 @ -гидроксихинолинового эфира 8-гидроксихинолин-7-карбоновой кислоты, в качестве бактерицида дл подавлени сульфатвосстанавливающих бактерий и культур РSеUDомоNаS и АRтнRовастеR
|
|
DE69129389T2
(de)
|
1990-06-28 |
1998-10-08 |
Fuji Photo Film Co Ltd |
Photographische Silberhalogenidmaterialien
|
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
|
HUT64064A
(en)
|
1992-02-13 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
AU3933493A
(en)
|
1992-04-24 |
1993-11-29 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal and fungicidal aminopyrimidines
|
|
TW229140B
(enExample)
|
1992-06-05 |
1994-09-01 |
Shell Internat Res Schappej B V |
|
|
FR2714907B1
(fr)
|
1994-01-07 |
1996-03-29 |
Union Pharma Scient Appl |
Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
|
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
|
JPH0987282A
(ja)
|
1995-09-21 |
1997-03-31 |
Kyowa Hakko Kogyo Co Ltd |
チアゾール誘導体
|
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
|
JPH09176116A
(ja)
|
1995-12-27 |
1997-07-08 |
Toray Ind Inc |
複素環誘導体およびその医薬用途
|
|
JPH1025294A
(ja)
|
1996-03-26 |
1998-01-27 |
Akira Matsuda |
縮合ヘテロ環誘導体、その製造法及びそれを含有する悪性腫瘍治療剤
|
|
JP4373497B2
(ja)
|
1996-06-19 |
2009-11-25 |
ローン−プーラン・ロレ・リミテツド |
置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
|
|
ES2232871T3
(es)
|
1996-07-03 |
2005-06-01 |
Sumitomo Pharmaceuticals Company, Limited |
Nuevos derivados de purina.
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
|
JPH10231297A
(ja)
|
1997-02-20 |
1998-09-02 |
Japan Energy Corp |
新規なアデニン−１−ｎ−オキシド誘導体およびその医薬用途
|
|
CA2309350C
(en)
|
1997-11-12 |
2007-04-03 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicaments comprising the same as active ingredient
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
CN1299347A
(zh)
|
1998-02-25 |
2001-06-13 |
遗传研究所有限公司 |
磷脂酶抑制剂
|
|
TR200002445T2
(tr)
|
1998-02-25 |
2000-12-21 |
Genetics Institute, Inc. |
Fosfolipaz inhibitörleri.
|
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
|
EP1109785B1
(de)
|
1998-05-04 |
2003-01-02 |
Zentaris AG |
Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
|
|
JP4549534B2
(ja)
|
1998-05-26 |
2010-09-22 |
中外製薬株式会社 |
複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体
|
|
JP3997651B2
(ja)
|
1998-06-24 |
2007-10-24 |
コニカミノルタホールディングス株式会社 |
新規色素及び画像記録材料及び感熱転写材料及びインクジェット記録液
|
|
WO2000009495A1
(en)
*
|
1998-08-11 |
2000-02-24 |
Novartis Ag |
Isoquinoline derivatives with angiogenesis inhibiting activity
|
|
JP2002523412A
(ja)
|
1998-08-25 |
2002-07-30 |
ザ ユーエイビー リサーチ ファウンデイション |
細菌ｎａｄシンテターゼ阻害剤
|
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
|
GEP20033092B
(en)
|
1999-02-01 |
2003-10-27 |
Cv Therapeutics Inc Us |
Purine Inhibitors of Cyclin Dependent Kinase 2 and Ik-Aa
|
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6436965B1
(en)
|
2000-03-02 |
2002-08-20 |
Merck Frosst Canada & Co. |
PDE IV inhibiting amides, compositions and methods of treatment
|
|
EP1138328A1
(en)
|
2000-03-29 |
2001-10-04 |
Eli Lilly And Company Limited |
Naphthalene derivatives as CNS drugs
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
PL202623B1
(pl)
|
2000-06-28 |
2009-07-31 |
Smithkline Beecham Plc |
Sposób wytwarzania drobno zmielonego preparatu substancji leczniczej, drobno zmielona substancja lecznicza wytworzona tym sposobem i zawierająca ją kompozycja farmaceutyczna
|
|
CN1331340A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人拓扑异构酶12.1和编码这种多肽的多核苷酸
|
|
CA2415010C
(en)
|
2000-07-05 |
2011-05-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Propane-1,3-dione derivatives useful as gnrh receptor antagonist
|
|
FR2814073B1
(fr)
|
2000-09-21 |
2005-06-24 |
Yang Ji Chemical Company Ltd |
Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
|
|
DOP2002000334A
(es)
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
|
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
PL365027A1
(en)
|
2001-03-01 |
2004-12-27 |
Shionogi & Co, Ltd. |
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
US7034030B2
(en)
|
2001-03-30 |
2006-04-25 |
Smithkline Beecham Corporation |
Pyralopyridines, process for their preparation and use as therapeutic compounds
|
|
WO2002078701A1
(en)
|
2001-03-30 |
2002-10-10 |
Smithkline Beecham Corporation |
Use of pyrazolopyridines as therapeutic compounds
|
|
US6962914B2
(en)
|
2001-04-27 |
2005-11-08 |
Smithkline Beecham Corporation |
Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
|
|
CZ294535B6
(cs)
|
2001-08-02 |
2005-01-12 |
Ústav Experimentální Botaniky Avčr |
Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
DE60230890D1
(de)
|
2001-09-19 |
2009-03-05 |
Aventis Pharma Sa |
Indolizine als kinaseproteinhemmer
|
|
CN1578781A
(zh)
|
2001-09-26 |
2005-02-09 |
拜尔药品公司 |
用作抗糖尿病药物的1,8－萘啶衍生物
|
|
EP1432714B1
(en)
|
2001-10-02 |
2008-08-06 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
MXPA04004137A
(es)
|
2001-10-30 |
2005-01-25 |
Novartis Ag |
Derivados de estauroesporina como inhibidores de la actividad de cinasa de tirosina del receptor flt3.
|
|
AU2002359364A1
(en)
|
2001-11-09 |
2003-05-26 |
Enzon, Inc. |
Polymeric thiol-linked prodrugs employing benzyl elimination systems
|
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
|
US7378411B2
(en)
|
2001-12-06 |
2008-05-27 |
Merck & Co., Inc. |
Substituted thienopyrimidinones as a mitotic kinesin inhibitor
|
|
WO2003049678A2
(en)
|
2001-12-06 |
2003-06-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
TW200301135A
(en)
|
2001-12-27 |
2003-07-01 |
Otsuka Maryland Res Inst Inc |
Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
|
|
EP1484320A1
(en)
|
2002-02-13 |
2004-12-08 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
|
AU2003225668A1
(en)
|
2002-03-01 |
2003-09-16 |
Pintex Pharmaceutical, Inc. |
Pin1-modulating compounds and methods of use thereof
|
|
EP1490371B1
(en)
|
2002-04-03 |
2007-08-15 |
Bristol-Myers Squibb Company |
Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
|
|
MXPA04010983A
(es)
|
2002-05-06 |
2005-02-14 |
Genelabs Tech Inc |
Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
|
JP3908248B2
(ja)
|
2002-08-13 |
2007-04-25 |
塩野義製薬株式会社 |
Ｈｉｖインテグラーゼ阻害活性を有するヘテロ環化合物
|
|
JP4190232B2
(ja)
|
2002-08-26 |
2008-12-03 |
富士通株式会社 |
機械研磨を行う方法
|
|
CA2497765A1
(en)
|
2002-09-27 |
2004-04-08 |
Sumitomo Pharmaceuticals Co., Ltd. |
8-hydroxy substituted adenine compounds and uses thereof
|
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
ES2412273T3
(es)
|
2002-11-21 |
2013-07-10 |
Novartis Ag |
Inhibidores de 2-morfolín-4-pirimidinas como inhibidores de fosfotidilinositol (PI) 3-quinasa y su uso en el tratamiento del cáncer.
|
|
EP1568688B1
(en)
|
2002-11-25 |
2011-08-31 |
Mochida Pharmaceutical Co., Ltd. |
Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
AU2003292625B2
(en)
|
2002-12-26 |
2008-07-24 |
Eisai R & D Management Co., Ltd. |
Selective estrogen receptor modulators
|
|
CZ294538B6
(cs)
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
|
RU2233842C1
(ru)
|
2003-01-13 |
2004-08-10 |
Петров Владимир Иванович |
Производные пурина, обладающие противовирусной активностью
|
|
AR043692A1
(es)
|
2003-02-06 |
2005-08-10 |
Novartis Ag |
2-cianopirrolopirimidinas y sus usos farmaceuticos
|
|
GB0304640D0
(en)
|
2003-02-28 |
2003-04-02 |
Novartis Ag |
Organic compounds
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
|
WO2004107863A1
(en)
|
2003-05-05 |
2004-12-16 |
Neurogen Corporation |
Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
|
|
AU2004249730A1
(en)
|
2003-06-20 |
2004-12-29 |
Novartis Vaccines And Diagnostics, Inc. |
Pyridino(1,2-A)pyrimidin-4-one compounds as anticancer agents
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
JP4570015B2
(ja)
|
2003-07-14 |
2010-10-27 |
クミアイ化学工業株式会社 |
２−イソオキサゾリン誘導体及びそれを有効成分として含有する除草剤
|
|
MXPA06001758A
(es)
|
2003-08-15 |
2006-08-11 |
Irm Llc |
Anilino purinas sustituidas en la posicion 6 utiles como inhibidores de rtk.
|
|
NZ546611A
(en)
|
2003-09-18 |
2010-02-26 |
Conforma Therapeutics Corp |
Novel heterocyclic compounds as HSP90-inhibitors
|
|
EP1667978B1
(en)
|
2003-09-23 |
2013-09-04 |
Merck Sharp & Dohme Corp. |
Isoquinolinone potassium channel inhibitors
|
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
|
JP2007520559A
(ja)
|
2004-02-03 |
2007-07-26 |
アボット・ラボラトリーズ |
治療薬としてのアミノベンゾオキサゾール類
|
|
EP1717238A4
(en)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
FUNGICIDES HETEROCYCLIC COMPOUNDS
|
|
CN1560035A
(zh)
|
2004-03-12 |
2005-01-05 |
沈阳药科大学 |
5－羟基吲哚－3－羧酸脂类衍生物
|
|
WO2005091857A2
(en)
|
2004-03-12 |
2005-10-06 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine and 1,8-naphthyridine derivatives and their use to treat diabetes and related disorders
|
|
WO2005092892A1
(ja)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
８−オキソアデニン化合物
|
|
EP1740587A4
(en)
|
2004-04-02 |
2009-07-15 |
Adenosine Therapeutics Llc |
SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS
|
|
CA2566609C
(en)
|
2004-05-13 |
2012-06-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US20060074102A1
(en)
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
|
CN101023082A
(zh)
|
2004-07-22 |
2007-08-22 |
阿斯利康(瑞典)有限公司 |
用于治疗和预防癌症的稠合嘧啶酮类
|
|
MX2007001953A
(es)
|
2004-08-18 |
2007-05-09 |
Astrazeneca Ab |
Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
|
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
BRPI0517314A
(pt)
|
2004-10-19 |
2008-10-07 |
Novartis Vaccines & Diagnostic |
derivados de indol e benzimidazol
|
|
US20080004269A1
(en)
|
2004-11-04 |
2008-01-03 |
Yuelian Xu |
Pyrazolylmethy Heteroaryl Derivatives
|
|
EP1831225A2
(en)
|
2004-11-19 |
2007-09-12 |
The Regents of the University of California |
Anti-inflammatory pyrazolopyrimidines
|
|
BRPI0517887A
(pt)
|
2004-11-24 |
2008-10-21 |
Novartis Ag |
combinações de inibidores de jaks
|
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
US7799795B2
(en)
|
2005-06-27 |
2010-09-21 |
Amgen Inc. |
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
|
|
FR2889192A1
(fr)
|
2005-07-27 |
2007-02-02 |
Cytomics Systems Sa |
Composes antifongiques, compositions contenant ces composes et leurs utilisations
|
|
EP1924265A4
(en)
|
2005-08-16 |
2010-06-02 |
Genzyme Corp |
COMPOUNDS BINDING TO CHEMOKINE RECEPTORS
|
|
US7642270B2
(en)
|
2005-09-14 |
2010-01-05 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
|
|
WO2007034817A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
PL1951684T3
(pl)
|
2005-11-01 |
2017-03-31 |
Targegen, Inc. |
Biarylowe meta-pirymidynowe inhibitory kinaz
|
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
|
ES2353549T3
(es)
|
2005-11-10 |
2011-03-03 |
Chemocentryx, Inc. |
Quinolonas sustituidas y métodos de uso.
|
|
EP2474545B1
(en)
|
2005-12-13 |
2016-11-09 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
US20100227880A1
(en)
|
2006-01-25 |
2010-09-09 |
Kristjan Gudmundsson |
Chemical compounds
|
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
WO2007102392A1
(ja)
|
2006-03-03 |
2007-09-13 |
Shionogi & Co., Ltd. |
Ｍｍｐ－１３選択的阻害剤
|
|
CA2647543A1
(en)
|
2006-03-29 |
2007-11-08 |
Foldrx Pharmaceuticals, Inc. |
Inhibition of alpha-synuclein toxicity
|
|
DK2004654T3
(da)
*
|
2006-04-04 |
2013-07-22 |
Univ California |
Pyrazolopyrimidin derivater til anvendelse som kinase antagonister
|
|
DE102006029074A1
(de)
*
|
2006-06-22 |
2007-12-27 |
Friedrich-Schiller-Universität Jena |
4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
|
|
ES2436028T3
(es)
|
2006-06-23 |
2013-12-26 |
Radius Health, Inc. |
Tratamiento de síntomas vasomotores con moduladores selectivos de receptores de estrógeno
|
|
EP2044086A2
(en)
|
2006-06-30 |
2009-04-08 |
Janssen Pharmaceutica N.V. |
Thiazolopyrimidine modulators of trpv1
|
|
US20080009508A1
(en)
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
|
EP2046788A1
(en)
|
2006-07-12 |
2009-04-15 |
Syngeta Participations AG |
Triazolopyridine derivatives as herbicides
|
|
SI2050749T1
(en)
|
2006-08-08 |
2018-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
DERIVAT PYRIMIDINE AS A PI3K INHIBITOR AND ITS USE
|
|
EP2057158B8
(en)
|
2006-08-30 |
2015-09-30 |
Cellzome Limited |
Triazole derivatives as kinase inhibitors
|
|
WO2008032033A1
(en)
|
2006-09-14 |
2008-03-20 |
Astrazeneca Ab |
4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
|
|
EP1972631A1
(en)
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
|
US20080114007A1
(en)
|
2006-10-31 |
2008-05-15 |
Player Mark R |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
|
|
KR20090087027A
(ko)
|
2006-11-13 |
2009-08-14 |
일라이 릴리 앤드 캄파니 |
염증 질환 및 암의 치료를 위한 티에노피리미디논
|
|
SI2497470T1
(sl)
|
2006-11-22 |
2016-02-29 |
Incyte Holdings Corporation |
Imidazotriazini in imidazopirimidini kot inhibitorji kinaz
|
|
WO2008082490A2
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
|
ES2351949T3
(es)
|
2006-12-29 |
2011-02-14 |
F. Hoffmann-La Roche Ag |
Derivados de azaspiro.
|
|
AR065194A1
(es)
|
2007-02-05 |
2009-05-20 |
Xenon Pharmaceuticals Inc |
Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio
|
|
MX2009008439A
(es)
|
2007-02-12 |
2009-08-13 |
Intermune Inc |
Nuevos inhibidores de la replicacion del virus de hepatitis c.
|
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
|
US20080233127A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
|
|
AU2008231384B2
(en)
|
2007-03-23 |
2011-09-15 |
Amgen Inc. |
Heterocyclic compounds and their use
|
|
HRP20160350T1
(hr)
|
2007-03-23 |
2016-05-06 |
Amgen Inc. |
Heterociklički spojevi i njihove uporabe
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
AU2008266856A1
(en)
|
2007-06-18 |
2008-12-24 |
University Of Louisville Research Foundation, Inc. |
Family of PFKFB3 inhibitors with anti-neoplastic activities
|
|
NZ582090A
(en)
|
2007-06-29 |
2012-05-25 |
Gilead Sciences Inc |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
JP2009076865A
(ja)
|
2007-08-29 |
2009-04-09 |
Fujifilm Corp |
有機電界発光素子
|
|
WO2009026701A1
(en)
|
2007-08-29 |
2009-03-05 |
Methylgene Inc. |
Sirtuin inhibitors
|
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
|
JP2009080233A
(ja)
|
2007-09-26 |
2009-04-16 |
Kyocera Mita Corp |
電子写真感光体
|
|
CZ300774B6
(cs)
|
2007-10-05 |
2009-08-05 |
Univerzita Palackého |
Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
|
|
CN101917999A
(zh)
|
2007-11-07 |
2010-12-15 |
弗尔德里克斯制药股份有限公司 |
蛋白质运输的调节
|
|
WO2009063235A1
(en)
|
2007-11-13 |
2009-05-22 |
Astrazeneca Ab |
Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018
|
|
JP2009120686A
(ja)
|
2007-11-14 |
2009-06-04 |
Toyo Ink Mfg Co Ltd |
光重合開始剤、重合性組成物、および重合物の製造方法。
|
|
CA2710194C
(en)
|
2007-12-19 |
2014-04-22 |
Amgen Inc. |
Inhibitors of p13 kinase
|
|
EP2219646A4
(en)
|
2007-12-21 |
2010-12-22 |
Univ Rochester |
PROCESS FOR EXTENDING THE LIFE OF EUKARYOTIC ORGANISMS
|
|
EP2231641B1
(en)
|
2007-12-21 |
2016-06-01 |
UCB Biopharma SPRL |
Quinoxaline and quinoline derivatives as kinase inhibitors
|
|
BRPI0822237A2
(pt)
|
2007-12-21 |
2015-06-30 |
Wyeth Llc |
Compostos de imidazo [1,2-a] piridina
|
|
US8410098B2
(en)
|
2007-12-28 |
2013-04-02 |
Topharman Shanghai Co., Ltd. |
N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)sulfonylphenyl)-4,5-dihydro-5-OXO-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
|
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
WO2009098715A2
(en)
|
2008-01-11 |
2009-08-13 |
Natco Pharma Limited |
Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
|
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
|
ES2494365T3
(es)
|
2008-01-30 |
2014-09-15 |
Genentech, Inc. |
Compuestos de pirazolopirimidina que inhiben PI3K y métodos de uso
|
|
EP2277881A4
(en)
|
2008-04-18 |
2011-09-07 |
Shionogi & Co |
HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
|
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
WO2009140215A2
(en)
|
2008-05-11 |
2009-11-19 |
Geraghty, Erin |
Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
|
|
EP2300005A4
(en)
|
2008-05-28 |
2011-07-13 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of U S Army Medical Res And Mate |
Small-molecule inhibitors of botulinum neurotoxins
|
|
KR20110026481A
(ko)
|
2008-06-20 |
2011-03-15 |
메타볼렉스, 인코포레이티드 |
아릴 ｇｐｒ１１９ 작동약 및 이의 용도
|
|
US8026271B2
(en)
|
2008-07-11 |
2011-09-27 |
National Health Research Institutes |
Formulations of indol-3-yl-2-oxoacetamide compounds
|
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
|
EP2346508B1
(en)
*
|
2008-09-26 |
2016-08-24 |
Intellikine, LLC |
Heterocyclic kinase inhibitors
|
|
CN102271683B
(zh)
|
2008-11-13 |
2014-07-09 |
吉里德卡利斯托加公司 |
恶性血液病的治疗
|
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
JP5657566B2
(ja)
|
2008-12-24 |
2015-01-21 |
バイアル ポルテラ アンド シーエイ エス エイＢＩＡＬ−Ｐｏｒｔｅｌａ ＆ Ｃａ， Ｓ．Ａ． |
医薬品
|
|
WO2010083444A1
(en)
|
2009-01-15 |
2010-07-22 |
Anvyl, Llc |
Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
|
|
EP2396315B1
(en)
|
2009-02-13 |
2016-08-31 |
UCB Biopharma SPRL |
Quinoline derivatives as pi3k kinase inhibitors
|
|
US8497276B2
(en)
|
2009-03-31 |
2013-07-30 |
Arqule, Inc. |
Substituted indolo-piperidine compounds
|
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
|
US8546409B2
(en)
|
2009-04-20 |
2013-10-01 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
|
WO2010129816A2
(en)
|
2009-05-07 |
2010-11-11 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2762174C
(en)
|
2009-05-22 |
2018-02-20 |
Incyte Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
CA2781865A1
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
EP2445898A2
(en)
|
2009-06-25 |
2012-05-02 |
Amgen, Inc |
4h-pyrido[1,2-a]pyrimidin-4-one derivatives as pi3k inhibitors
|
|
AR077280A1
(es)
|
2009-06-29 |
2011-08-17 |
Incyte Corp |
Pirimidinonas como inhibidores de pi3k, y composiciones farmaceuticas que los comprenden
|
|
CR20170071A
(es)
|
2009-06-29 |
2017-03-28 |
Agios Pharmaceuticals Inc |
Compuestos terapeuticos y composiciones
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
WO2011011550A1
(en)
|
2009-07-21 |
2011-01-27 |
Calistoga Pharmaceuticals Inc. |
Treatment of liver disorders with pi3k inhibitors
|
|
SI2470546T1
(sl)
|
2009-08-28 |
2013-12-31 |
Takeda Pharmaceutical Company Limited |
Spojine heksahidrooksazinopteridina za uporabo kot MTOR inhibitorji
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
KR20120102601A
(ko)
|
2009-10-20 |
2012-09-18 |
셀좀 리미티드 |
Ｊａｋ 저해제로서의 헤테로시클릴 피라졸로피리미딘 유사체
|
|
PE20121091A1
(es)
|
2009-10-22 |
2012-08-17 |
Gilead Sciences Inc |
Derivados de purina o deazapurina utiles en el tratamiento de (inter alia) infecciones virales
|
|
MX352661B
(es)
|
2009-11-05 |
2017-12-04 |
Rhizen Pharmaceuticals S A Star |
Moduladores novedosos de benzopiran cinasa.
|
|
AP3283A
(en)
|
2009-11-10 |
2015-05-31 |
Pfizer |
N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
EP2499126B1
(en)
|
2009-11-12 |
2015-01-07 |
UCB Pharma, S.A. |
Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
|
|
WO2011058111A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Aminopurine derivatives as kinase inhibitors
|
|
CA2783859A1
(en)
|
2009-12-10 |
2011-06-16 |
Institute Of Materia Medica, Chinese Academy Of Medical Sciences |
N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof
|
|
EP2513109A1
(en)
|
2009-12-18 |
2012-10-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
AR079529A1
(es)
|
2009-12-18 |
2012-02-01 |
Incyte Corp |
Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
RU2573828C2
(ru)
*
|
2009-12-23 |
2016-01-27 |
Медисиз Фармасьютикал Корпорейшн |
Производные аминоалкилпиримидина в качестве антагонистов h4 рецептора гистамина
|
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
|
WO2011085084A1
(en)
|
2010-01-07 |
2011-07-14 |
Dow Agrosciences Llc |
THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS
|
|
US8633183B2
(en)
|
2010-01-26 |
2014-01-21 |
Boehringer Ingelheim International Gmbh |
5-alkynyl-pyrimidines
|
|
ME02386B
(me)
|
2010-03-10 |
2016-09-20 |
Incyte Holdings Corp |
Derivati piperidin-4-il azetidina kao inhibitori jak1
|
|
EP2549998A1
(en)
|
2010-03-22 |
2013-01-30 |
Glenmark Pharmaceuticals S.A. |
Pharmaceutical composition comprising a pyrimidineone derivative
|
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
|
US9193721B2
(en)
|
2010-04-14 |
2015-11-24 |
Incyte Holdings Corporation |
Fused derivatives as PI3Kδ inhibitors
|
|
SG185567A1
(en)
|
2010-05-21 |
2012-12-28 |
Incyte Corp |
Topical formulation for a jak inhibitor
|
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
|
US20110306622A1
(en)
|
2010-06-11 |
2011-12-15 |
Calitoga Pharmaceuticals, Inc. |
Methods of treating hematological disorders with quinazolinone compounds in selected subjects
|
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
|
US8759371B2
(en)
|
2010-07-01 |
2014-06-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
MX2012015135A
(es)
|
2010-07-01 |
2013-05-06 |
Amgen Inc |
Compuestos heterociclicos y su uso como inhibidores de la actividad pi3k.
|
|
CA2803624A1
(en)
|
2010-07-02 |
2012-01-05 |
Jason A. Duquette |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
|
CA2812467A1
(en)
|
2010-09-24 |
2012-03-29 |
Gilead Calistoga Llc |
Atropisomers of pi3k-inhibiting compounds
|
|
AU2011323243A1
(en)
|
2010-11-04 |
2013-05-23 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
AU2011326427B2
(en)
|
2010-11-10 |
2016-01-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
MX2013005567A
(es)
|
2010-11-17 |
2013-10-30 |
Amgen Inc |
Derivados de quinolina como inhibidores de pik3.
|
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
|
US8933085B2
(en)
|
2010-11-19 |
2015-01-13 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
|
CN103298460B
(zh)
|
2010-12-14 |
2016-06-01 |
电泳有限公司 |
酪蛋白激酶1δ(CK1δ)抑制剂
|
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
|
WO2012087784A1
(en)
|
2010-12-23 |
2012-06-28 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
EP2663309B1
(en)
|
2011-01-10 |
2017-03-15 |
Infinity Pharmaceuticals, Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
WO2012106343A2
(en)
|
2011-02-01 |
2012-08-09 |
The Board Of Trustees Of The University Of Illinois |
Hdac inhibitors and therapeutic methods using the same
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
BR112013032720A2
(pt)
|
2011-06-20 |
2016-09-13 |
Incyte Corp |
"derivados de azetidinil fenil, piridil ou pirazinil carboxamida como inibidores de jak, composição e uso dos referidos derivados"
|
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
IL299533B2
(en)
|
2011-09-02 |
2025-01-01 |
Incyte Holdings Corp |
Heterocycloamines as PI3K inhibitors
|
|
CN104024257A
(zh)
|
2011-10-04 |
2014-09-03 |
吉利德卡利斯托加有限责任公司 |
Pi3k的新的喹喔啉抑制剂
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
|
PE20151141A1
(es)
|
2012-11-01 |
2015-08-06 |
Incyte Corp |
Derivados triciclicos fusionados de tiofeno como inhibidores de jak
|
|
TWI736135B
(zh)
|
2013-03-01 |
2021-08-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
|
ES2924193T3
(es)
|
2013-03-15 |
2022-10-05 |
Janssen Pharmaceutica Nv |
Procesos e intermedios para preparar un medicamento
|
|
KR102729910B1
(ko)
|
2013-05-17 |
2024-11-15 |
인사이트 홀딩스 코포레이션 |
Ｊａｋ 저해제로서 비피라졸 유도체
|
|
DK3129021T3
(da)
|
2014-04-08 |
2020-11-09 |
Incyte Corp |
Behandling af b-celle-maligniteter ved en kombination af jak- og pi3k-inhibitorer
|
|
MD20160132A2
(ro)
|
2014-05-27 |
2017-05-31 |
Almirall S.A. |
Săruri de adiţie ale (S)-2-(1-(6-amino-5-cianopirimidin-4-ilamino)etil)-4-oxo-3-fenil-3,4-dihidropirolo[1,2-f][1,2,4]triazin-5-carbonitrilului
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
TWI698436B
(zh)
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶７抑制劑之吡咯并及吡唑并嘧啶
|
|
SG11201706917WA
(en)
|
2015-02-27 |
2017-09-28 |
Incyte Corp |
Salts of pi3k inhibitor and processes for their preparation
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
WO2016183063A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Crystalline forms of a pi3k inhibitor
|
|
US20160362424A1
(en)
|
2015-05-11 |
2016-12-15 |
Incyte Corporation |
Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one
|
|
SG11202011680YA
(en)
|
2018-06-01 |
2020-12-30 |
Incyte Corp |
Dosing regimen for the treatment of pi3k related disorders
|
|
WO2023114369A2
(en)
|
2021-12-16 |
2023-06-22 |
Incyte Corporation |
Topical formulations of pi3k-delta inhibitors
|